ReviewOrphanet journal of rare diseases2025
Current status of the immunogenicity of enzyme replacement therapy in fabry disease.
Jorge F Gómez-Cerezo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it